Li Ren
Impact in
-
- Cancer, Hypoxia, and Metabolism
-
- Cancer Cells and Metastasis
- Peptidase Inhibition and Analysis
Papers in
- Oncology 14
- Pancreatic and Hepatic Oncology Research 5
-
- Cancer, Lipids, and Metabolism 5
- Cancer, Hypoxia, and Metabolism 5
- Co-authors
- Duo Zuo (9 shared papers)Liu R (1 shared paper)Yanjie He (1 shared paper)Lyu Zhou (1 shared paper)Guoguang Ying (1 shared paper)Ting Deng (1 shared paper)Yi Ba (1 shared paper)Jingwen Chen (1 shared paper)
- Journals
- Blood (3 papers)Cancer Biology and Medicine (2 papers)PLoS ONE (2 papers)Frontiers in Cell and Developmental Biology (1 paper)Nature Communications (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Li Ren
32 papers receiving 379 citations
Peers
Comparison fields: 5 of 89
- Cancer Research 96
- Oncology 94
- Hepatology 27
- Cell Biology 55
- Molecular Biology 175
Countries citing papers authored by Li Ren
This map shows the geographic impact of Li Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ren more than expected).
Fields of papers citing papers by Li Ren
This network shows the impact of papers produced by Li Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ren. The network helps show where Li Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 77 | |
| 2 | 2020 | 60 | |
| 3 | 2021 | 28 | |
| 4 | 2021 | 28 | |
| 5 | 2019 | 20 | |
| 6 | 2013 | 14 | |
| 7 | 2019 | 14 | |
| 8 | 2015 | 12 | |
| 9 | 2018 | 11 | |
| 10 | 2019 | 10 | |
| 11 | 2021 | 9 | |
| 12 | 2012 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2022 | 8 | |
| 15 | 2014 | 7 | |
| 16 | 2021 | 7 | |
| 17 | 2015 | 7 | |
| 18 | 2024 | 6 | |
| 19 | 2020 | 6 | |
| 20 | 2024 | 6 |
About Li Ren
Li Ren is a scholar working on Oncology, Cancer Research, Molecular Biology, Epidemiology and Hepatology, having authored 36 papers that have together received 385 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Multiple Myeloma Research and Treatments (4 papers), Parasitic infections in humans and animals (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (96 citations), Oncology (94 citations), Hepatology (27 citations), Cell Biology (55 citations) and Molecular Biology (175 citations). Li Ren has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Duo Zuo, Liu R, Yanjie He, Lyu Zhou, Guoguang Ying, Ting Deng, Yi Ba, Jingwen Chen, Wentao Tang and Mi Jian. Their work appears in journals such as Blood, Cancer Biology and Medicine, PLoS ONE, Frontiers in Cell and Developmental Biology and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.